Complements and further expands ReciBioPharm's AAV offering The Xcell-Eng-HEK293 cell lines are high-value solutions for manufacturing recombinant adeno-associated viruses (rAAV) for use in C>.

Optibumin® 25 – a 25% recombinant human serum albumin (rHSA ... in 100 mL single-use bags and is suitable for integration into viral vector manufacturing, stem cell preservation, vaccine formulation, ...

Empathetic and persistent communication is key when it comes to talking to parents who are reluctant to vaccinate their child ...

Filoviruses are among the globe's most lethal—indeed, so dangerous they can be handled only in high-security laboratories. Yet, more than five decades after the discovery of the Marburg virus and ...

A total of twenty-five mice were randomly divided into five groups to evaluate the immunogenicity of the recombinant HSV-vector-based SIV vaccine. During the initial week, each mouse was ...

We discuss inactivated vaccines, virally and bacterially vectored vaccines, recombinant protein and ... Inactivated virus, viral vector, bacterial vector, subunit and DNA vaccines encoding several ...

Treatment with fidanacogene elaparvovec, a recombinant adeno-associated virus (AAV) vector developed for the treatment of hemophilia B, led to sustained expression of the high-activity factor IX ...

“That will give us the platform we need for quick vaccine developments,” explains Pelka. “The goal would be to develop new viral vector vaccines quickly, hopefully in 100 days or les ...

The Korea Disease Control and Prevention Agency said Tuesday that BARYTHRAX, a recombinant protein anthrax vaccine developed in collaboration with biopharmaceutical company GC Pharma, has been ...